Expert Opinion on Therapeutic Targets

The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury
pp. 783-794(12)
Authors: Suzuki, Jun-ichi; Ogawa, Masahito; Muto, Susumu; Yamaguchi, Yoichi; Itai, Akiko; Isobe, Mitsuaki

MAPK phosphatases as novel targets for rheumatoid arthritis
pp. 795-808(14)
Authors: Ralph, Jennifer A; Morand, Eric F

Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?
pp. 809-820(12)
Authors: Tziomalos, Konstantinos; Athyros, Vasilios G; Karagiannis, Asterios; Mikhailidis, Dimitri P

Molecular diagnosis of the viral component in cardiomyopathies: pathophysiological, clinical and therapeutic implications
pp. 821-836(16)
Authors: Halapas, A; Pissimissis, N; Lembessis, P; Rizos, I; Rigopoulos, AG; Kremastinos, DT; Koutsilieris, M

Eag1 as a cancer target
pp. 837-843(7)
Authors: Pardo, Luis A; Sühmer, Walter

Potential role of EPB41L3 (Protein 4.1B/Dal-1) as a target for treatment of advanced prostate cancer
pp. 845-853(9)
Authors: Bernkopf, Dominic B; Williams, Elizabeth D

Molecular targeting of E3 ligases - a therapeutic approach for cancer
pp. 855-870(16)
Authors: Lakshmanan, Manikandan; Bughani, Usha; Duraisamy, Senthil; Diwan, Manish; Dastidar, Sunanda; Ray, Abhijit

From hyperglycemia to AGE-RAGE interaction on the cell surface: A dangerous metabolic route for diabetic patients
pp. 871-882(12)
Authors: Nogueira-Machado, José Augusto; Chaves, Miriam Martins

Kinase inhibitors as drugs for chronic inflammatory and immunological diseases: progress and challenges
pp. 883-903(21)
Authors: Rokosz, Laura L; Beasley, James R; Carroll, Carolyn DiIanni; Lin, Tsung; Zhao, Jiuqiao; Appell, Kenneth C; Webb, Maria L

Rogue proliferation versus restorative protection: Where do we draw the line for Wnt and Forkhead signaling?
pp. 905-916(12)
Authors: Maiese, Kenneth; Chong, Zhao Zhong; Shang, Yan Chen; Hou, Jinling